SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-008295 to MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982) (MMSI)

MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982)
Date: July 22, 2024 · CIK: 0000856982 · Accession: 0000000000-24-008295

AI Filing Summary & Sentiment

File numbers found in text: 000-18592

Referenced dates: July 12, 2024

Date
July 22, 2024
Author
Not clearly detected
Form
UPLOAD
Company
MERIT MEDICAL SYSTEMS INC (MMSI) (CIK 0000856982)

Letter

July 22, 2024 Raul Parra Chief Financial Officer and Treasurer MERIT MEDICAL SYSTEMS INC 1600 West Merit Parkway South Jordan , Utah 84095 Re:MERIT MEDICAL SYSTEMS INC Form 10-K for Fiscal Year Ended December 31, 2023 Filed February 28, 2024 Form 8-K Filed February 28, 2024 Response Letter Dated July 12, 2024 File No. 000-18592 Dear Raul Parra: We have reviewed your July 12, 2024 response to our comment letter and have the following comment. Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our June 10, 2024 letter. Form 8-K Filed February 28, 2024 Exhibit 99.1 1.We note your response to our comment letter. Based on the information provided for the Foundations for Growth Program costs captured in the corporate transformation and restructuring non-GAAP adjustment, these costs appear to have been incurred in the normal course of your operations. With reference to Question 100.01 of the Compliance and Disclosure Interpretations for Non-GAAP Financial Measures, please confirm that you will no longer exclude the corporate transformation costs from your non-GAAP measures.

July 22, 2024 Page 2 Please contact Tracey Houser at 202-551-3736 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services

Show Raw Text
July 22, 2024
Raul Parra
Chief Financial Officer and Treasurer
MERIT MEDICAL SYSTEMS INC
1600 West Merit Parkway
South Jordan , Utah 84095
Re:MERIT MEDICAL SYSTEMS INC
Form 10-K for Fiscal Year Ended December 31, 2023
Filed February 28, 2024
Form 8-K Filed February 28, 2024
Response Letter Dated July 12, 2024
File No. 000-18592
Dear Raul Parra:
            We have reviewed your July 12, 2024  response to our comment letter and have the
following comment.
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments. Unless we
note otherwise, any references to prior comments are to comments in our June 10, 2024 letter.
Form 8-K Filed February 28, 2024
Exhibit 99.1
1.We note your response to our comment letter.  Based on the information provided for the
Foundations for Growth Program costs captured in the corporate transformation and
restructuring non-GAAP adjustment, these costs appear to have been incurred in the
normal course of your operations. With reference to Question 100.01 of the Compliance
and Disclosure Interpretations for Non-GAAP Financial Measures, please confirm that
you will no longer exclude the corporate transformation costs from your non-GAAP
measures.

July 22, 2024
Page 2
            Please contact Tracey Houser at 202-551-3736 or Al Pavot at 202-551-3738 if you have
questions regarding comments on the financial statements and related matters.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services